Postes actifs de Jaime Simon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
IGL Pharma, Inc.
 IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Directeur/Membre du Conseil | 01/01/2016 | - |
| Fondateur | 01/01/2016 | - | |
IsoTherapeutics Group LLC
 IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million. | Directeur Technique/Scientifique/R&D | 01/01/2005 | - |
| Fondateur | 01/01/2005 | - |
Historique de carrière de Jaime Simon
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
IGL Pharma, Inc.
IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Health Services |
IsoTherapeutics Group LLC
IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million. | Health Technology |
- Bourse
- Insiders
- Jaime Simon
- Expérience
